Skip to content

Effects of Melissa in decreasing stress, anxiety and insomnia as well as increasing body`s antioxidant

Comparison between herb drink of Melissa and black tea in decreasing stress, anxiety and insomnia as well as increasing body`s antioxidant among hospitalized burn patients in Shahid Motahari Hospital

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201205198177N4
Enrollment
36
Registered
2013-08-22
Start date
2013-07-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Generalized anxiety disorder. Condition 2: Depressive episode. Condition 3: Nonorganic insomnia. Anxiety that is generalized and persistent but not restricted to, or even strongly predominating in, any particular environmental circumstances (i.e. it is In typical mild, moderate, or severe depressive episodes, the patient suffers from lowering of mood, reduction of energy, and decrease in activity. Capacity for enjoyment, interest, and concentration is reduced, and marked tiredness

Interventions

Intervention 1: Intervention: patients are drinking one glass of Melissa tea in the mornings and one glass of Melissa tea in the evenings for 20 days from the first day of intervention. This tea is te
Treatment - Drugs
Placebo
Intervention: patients are drinking one glass of Melissa tea in the mornings and one glass of Melissa tea in the evenings for 20 days from the first day of intervention. This tea is teabag with the co
Control: Patients are drinking one glass of black tea in the mornings and one glass of black tea in the evenings for 20 days from the first day of intervention.

Sponsors

Vice chancellor for research of Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criterion: age of 18 to 70 years, 35% to 55% burn percentage, need of being hospitalized. Exclusion criterion: pregnancy, lactation, intention to become pregnant during the course of the study, consumption of anti-anxiety drugs or antidepressants or sedative 10 days before the start of the study, diabetes, asthma, hypo- and hyperthyroidism, depression, schizophrenia or psychosis, consumption of serotonin-reuptake inhibitors drugs.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Total body Antioxidant. Timepoint: In the first day of intervention and 20 days after. Method of measurement: Spectrophotometry techniques.;Anxiety. Timepoint: In the first day of intervention and 20 days after. Method of measurement: Ketel Questionnaire.;Depression. Timepoint: In the first day of intervention and 20 days after. Method of measurement: Standard Questionnaire of Beck.;Insomnia. Timepoint: In the first day of intervention and 20 days after. Method of measurement: Petersburg Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Javad Fatemi

Burn Research Center of Iran University of Medical sciences

mj-fatemi@sina.tums.ac.ir+98 21 8888 4275

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026